eli lilly and company retatrutide Retatrutide, Lilly's next obesity drug, fueled dramatic weight loss in clinical trial Today, we shared new data

For those who choose to take low-dose GLP-1s, a medical expert also advises seeking out continuous, certified care

Do not remove the outer or inner needle caps yet

In the over 2500 participants, who were assigned to the 5, 10, and 15 mg doses of tirzepatide and placebo, the percent weight changes were both statistically and clinically significant compared with placebo

Start with a clean workspace

STEP1, Semaglutide Treatment Effect in People with obesity 1

Microdosing could also be rising in popularity as a way for these medicines to be more cost-effective during shortages. She says taking a low dose may also be appropriate for people who: want to avoid or minimize side effects of a particular medication, or have a history of being sensitive to medication side effects